Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Impact of chromosome 2 obesity loci on cardiovascular complications of insulin
resistance in LDL receptor-deficient C57BL/6 mice.
Authors
Estrada-Smith D, Collins AR, Wang X, Crockett C, Castellani L, Lusis AJ, Davis
RC
Submitted By
Richard Davis on 2/11/2009
Status
Published
Journal
Diabetes
Year
2006
Date Published
8/1/2006
Volume : Pages
55(8) : 2265 - 2271
PubMed Reference
16873689
Abstract
Previous characterization of mouse chromosome 2 identified genomic intervals
that influence obesity, insulin resistance, and dyslipidemia. For this,
resistant CAST/Ei (CAST) alleles were introgressed onto a susceptible C57BL/6J
background to generate congenic strains with CAST alleles encompassing 67-162 Mb
(multigenic obesity 6 [MOB6]) and 84-180 Mb (MOB5) from mouse chromosome 2. To
examine the effects of each congenic locus on atherosclerosis and glucose
disposal, we bred each strain onto a sensitizing LDL receptor-null (LDLR(-/-))
C57BL/6J background to predispose them to hypercholesterolemia and insulin
resistance. LDLR(-/-) congenics and controls were characterized for measures of
atherogenesis, insulin sensitivity, and obesity. We identified a genomic
interval unique to the MOB6 congenic (72-84 Mb) that dramatically decreased
atherosclerosis by approximately threefold and decreased insulin resistance.
This region also reduced adiposity twofold. Conversely, the congenic region
unique to MOB5 (162-180 Mb) increased insulin resistance but had little effect
on atherosclerosis and adiposity. The MOB congenic intervals are concordant to
human and rat quantitative trait loci influencing diabetes and atherosclerosis
traits. Thus, our results define a strategy for studying the poorly understood
interactions between diabetes and atherosclerosis and for identifying genes
underlying the cardiovascular complications of insulin resistance.
Investigators with authorship
Name
Institution
Richard Davis
University of California Los Angeles
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Genes
Symbol
Description
Mob6
multigenic obesity 6
Mob5
multigenic obesity 5
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!